-
1
-
-
0037653669
-
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration one-year results
-
Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration one-year results. Arch Ophthalmol 2003;121:667-673.
-
(2003)
Arch Ophthalmol
, vol.121
, pp. 667-673
-
-
Gillies, M.C.1
Simpson, J.M.2
Luo, W.3
-
2
-
-
0036240895
-
Intravitreal triamcinolone for refractory diabetic macular oedema
-
Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 2002;109:920-927.
-
(2002)
Ophthalmology
, vol.109
, pp. 920-927
-
-
Martidis, A.1
Duker, J.S.2
Greenberg, P.B.3
-
3
-
-
1542317855
-
Safety of an intravitreal injection of triamcinolone results from a randomized clinical trial
-
Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone results from a randomized clinical trial. Arch Ophthalmol 2004;122:336-340.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 336-340
-
-
Gillies, M.C.1
Simpson, J.M.2
Billson, F.A.3
-
4
-
-
0345827866
-
Prophylaxis of acute posttraumatic bacterial endophthalmitis with or without combined intraocular antibiotics: A prospective, double-masked randomized pilot study
-
Soheilian M, Rafati N, Peyman GA. Prophylaxis of acute posttraumatic bacterial endophthalmitis with or without combined intraocular antibiotics: a prospective, double-masked randomized pilot study. Int Ophthalmol 2001;24:323-330.
-
(2001)
Int Ophthalmol
, vol.24
, pp. 323-330
-
-
Soheilian, M.1
Rafati, N.2
Peyman, G.A.3
-
5
-
-
0031872845
-
Treatment outcomes of endogenous fungal endophthalmitis
-
Smiddy WE. Treatment outcomes of endogenous fungal endophthalmitis. Curr Opin Ophthalmol 1998;9:66-70.
-
(1998)
Curr Opin Ophthalmol
, vol.9
, pp. 66-70
-
-
Smiddy, W.E.1
-
6
-
-
0030943532
-
Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome
-
Taskintuna I, Rahhal FM, Arevalo JF, et al. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1997;104:1049-1057.
-
(1997)
Ophthalmology
, vol.104
, pp. 1049-1057
-
-
Taskintuna, I.1
Rahhal, F.M.2
Arevalo, J.F.3
-
7
-
-
14744272836
-
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study
-
Jonas JB, Degenring RF, Krissig I, et al. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye 2005;19:163-170.
-
(2005)
Eye
, vol.19
, pp. 163-170
-
-
Jonas, J.B.1
Degenring, R.F.2
Krissig, I.3
-
8
-
-
0036129304
-
Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment
-
Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002;120:338-346.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 338-346
-
-
Krzystolik, M.G.1
Afshari, M.A.2
Adamis, A.P.3
-
9
-
-
0345827805
-
Technology evaluation: Pegaptanib, Eyetech/ Pfizer
-
Vinores SA. Technology evaluation: pegaptanib, Eyetech/ Pfizer. Curr Opin Mol Ther 2003;5:673-679.
-
(2003)
Curr Opin Mol Ther
, vol.5
, pp. 673-679
-
-
Vinores, S.A.1
-
10
-
-
33750302013
-
-
Available at
-
Available at: www.pfizer.com/pfizer/download/uspi_macugen.pdf.
-
-
-
-
11
-
-
6344263392
-
Evolving guidelines for intravitreous injections
-
Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3-S19.
-
(2004)
Retina
, vol.24
-
-
Aiello, L.P.1
Brucker, A.J.2
Chang, S.3
-
12
-
-
33644875826
-
Lidocaine gel anesthesia for intravitreal drug administration
-
Kozak I, Cheng L, Freeman WR. Lidocaine gel anesthesia for intravitreal drug administration. Retina 2005;25:994 -998.
-
(2005)
Retina
, vol.25
, pp. 994-998
-
-
Kozak, I.1
Cheng, L.2
Freeman, W.R.3
|